Ingrid Roskos, MD
Obstetrics & Gynecology · Slidell, LANPI 1235113770
Payments from drug & device makers
Across 290 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$769
- Evofem Biosciences, Inc.$497
- Astellas Pharma US Inc$418
- Mayne Pharma Commercial LLC$351
- Sumitomo Pharma America, Inc.$282
- Therapeuticsmd, Inc.$227
- plus $2K from 33 others
What the payments were for
- Consulting fees$341%
- Food & beverage$4,69099%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $769 |
| Evofem Biosciences, Inc. | 34 | $497 |
| Astellas Pharma US Inc | 24 | $418 |
| Mayne Pharma Commercial LLC | 20 | $351 |
| Sumitomo Pharma America, Inc. | 17 | $282 |
| Therapeuticsmd, Inc. | 16 | $227 |
| Mylan Pharmaceuticals Inc. | 15 | $211 |
| Bayer | 12 | $173 |
| Hologic Sales And Service, LLC | 7 | $162 |
| Avion Pharmaceuticals | 9 | $150 |
| Myovant Sciences Inc. | 10 | $149 |
| Organon | 8 | $143 |
| Pfizer | 7 | $134 |
| Avanos Medical | 2 | $132 |
| Daiichi Sankyo Inc. | 6 | $116 |
| Scynexis, Inc. | 6 | $111 |
| Millicent US Inc | 6 | $105 |
| Exact Sciences | 3 | $62 |
| Merck | 3 | $52 |
| Asensus Surgical, Inc. | 3 | $47 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| Coopersurgical, Inc. | 3 | $39 |
| Alfasigma USA, Inc. | 2 | $39 |
| Lupin Inc. | 3 | $37 |
| Innovation Technologies Inc | 1 | $29 |
| Heron Therapeutics, Inc. | 1 | $28 |
| Vertical Pharmaceuticals, LLC | 2 | $27 |
| Novo Nordisk | 2 | $27 |
| Johnson & Johnson | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Roche Diagnostics Corporation | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $18 |
| BD | 1 | $18 |
| Vertex | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $13 |
| Abbott | 1 | $12 |
| Renovia Inc | 1 | $11 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$4,735 in reported general payments places this provider in the 85th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 36 | $2,548 |
| Estradiol | 18 | $773 |
| Spironolactone | 37 | $398 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Slidell
- Blake LandrySlidell$2M
- Alison RodriguezNew Orleans$10.5M
- Scott StriplinCovington$6.1M
- Samuel AlexanderMetairie$2.6M
- Clifton Nicholson-UhlMarrero$1.7M
- Brandon PerezMarrero$888K
- Earl PeeperNew Orleans$374K
- Veronica GillispieNew Orleans$237K
- Monty HeinenEunice$214K
- Rachel Bezdekla Place$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.